The global pharmaceutical industry experienced an 11% drop in new job postings related to cell & gene therapy in Q3 2023 compared with the previous quarter, according to GlobalData’s Job Analytics. This compares to a 27% increase versus Q3 2022. GlobalData’s Pharma: Hiring Trends & Signals Q3 2023 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Smarter leaders trust GlobalData
Notably, Management Occupations jobs accounted for a 26% share of the global pharmaceutical industry’s cell & gene therapy-related total new job postings in Q3 2023, down 24% over the prior quarter.
Management Occupations drive cell & gene therapy-related hiring activity
Management Occupations, with a share of 26%, emerged as the top cell & gene therapy-related job roles within the pharmaceutical industry in Q3 2023, with new job postings drop by 24% quarter-on-quarter. Life, Physical, and Social Science Occupations came in second with a share of 19% in Q3 2023, with new job postings dropping by 9% over the previous quarter.
See Also:
The other prominent cell & gene therapy roles include Computer and Mathematical Occupations with a 9% share in Q3 2023, Business and Financial Operations Occupations with a 5% share of new job postings.
Top five companies in pharmaceutical industry accounted for 65% of hiring activity
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q3 2023 were Bristol-Myers Squibb, F. Hoffmann-La Roche, Charles River Laboratories International, Astellas Pharma, and Sarepta Therapeutics. Together they accounted for a combined share of 65% of all cell & gene therapy-related new jobs in the pharmaceutical industry.
Bristol-Myers Squibb posted 1,863 cell & gene therapy-related new jobs in Q3 2023, F. Hoffmann-La Roche 99 jobs, Charles River Laboratories International 88 jobs, Astellas Pharma 70 jobs, and Sarepta Therapeutics 66 jobs, according to GlobalData’s Job Analytics.
Hiring activity was driven by the US with a 66.23% share of total new job postings, Q3 2023
The largest share of cell & gene therapy-related new job postings in the pharmaceutical industry in Q3 2023 was in the US with 66.23% followed by India (10.94%) and China (4.09%). The share represented by the US was one percentage point lower than the 67.40% share it accounted for in Q2 2023.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q3 2023, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Jobs Analytics uses machine learning to uncover key insights from tracking daily job postings for thousands of companies globally. Proprietary analysis is used to group jobs into key thematic areas and granular sectors across the world’s largest industries. classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
